Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: A system and method for remote monitoring and/or management of infusion therapies. A user can monitor and manage server-connected pumps at a remote location, such as a computer or PDA. Pumps located at an institution, such as a hospital or patients home, are connected, for example, via the Internet to a server that includes a database of information. A user can operate the pump, from a remote location, by using an interface displayed on the remote site. The operator can manage pump operations by use of the interface. In this context, the user can turn the pump on and off, select infusion rates, dose amounts, etc. all from the convenience of the remote location.

Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.

Abstract: An improved medical thermometer is disclosed that provides an accurate estimate of a patient's temperature in substantially reduced time as compared to prior thermometers of this kind. This improved performance is achieved by configuring the thermometer to include a hollow, thin-walled metallic probe tip sized for secure attachment to the remote end of an elongated base. This defines an elongated cavity within the probe tip, and a thermistor is bonded to the probe tip within that cavity. The cavity is configured to be substantially longer in the direction of the probe's longitudinal axis than it is in a transverse direction, to inhibit the conduction of heat along the probe tip to the elongated base. The temperature of the thermistor, therefore, closely follows the temperature of any surface that contacts the metallic tip.

Abstract: An improved prediction-type medical thermometer that provides an accurate estimate of a patient's temperature in substantially reduced time as compared to prior thermometers of this kind. This improved performance is achieved by using a special hollow probe tip having a low heat capacity and incorporating a resistive heater that is actuated only upon removal of the probe from a base housing. In particular, a processor measures an initial temperature upon the probe's removal and applies to the heater an initial electrical signal having prescribed parameter, e.g., pulse duration, that varies according to the initial temperature measurement. This warms the probe to a prescribed temperature at or near about 93.degree. F., after which the processor applies a sequence of pulses to the heater, to controllably regulate the probe's temperature to the prescribed value.

Abstract: Jerky products having a high proportion of meat are produced on a mass production basis. Meat which is at least substantially frozen is comminuted and then heated to a temperature of least about 140.degree. F. to at least partially denature protein of the meat. The cooked meat is then cooled to a temperature sufficiently low to solidify the fat which melted during the cooking step. A binding agent, most preferably a cold water soluble starch and guar gum, is admixed with the cooked meat to compensate for the loss of binding power resulting from denaturing of the protein during the cooking step. Mixing of the binding agent with the cooled, cooked meat and other ingredients such as seasonings and fillers is conducted to obtain a machinable meat-based dough.

Abstract: An improved prediction-type medical thermometer that provides an accurate estimate of a patient's temperature in substantially reduced time as compared to prior thermometers of this kind. This improved performance is achieved by using a special hollow probe tip having a low heat capacity and incorporating a resistive heater that is actuated only upon removal of the probe from a base housing. The heater regulates the temperature to a value of about 93.degree. F. After the probe is applied to the patient, a microprocessor repeatedly samples the thermistor and estimates the patient's temperature based on the successive samples. If a predetermined number of successive temperature estimates lie within a predetermined error range, the sampling is terminated and the most recent estimate is displayed as the patient's temperature.

Abstract: A coated, baked canine biscuit having enhanced palatability. The edible coating includes: (a) about 20 to about 40 weight percent of at least one dextrin or at least one maltodextrin; (b) about 0.2 to about 2 weight percent of at least one edible acidulent; (c) about 0.1 to about 1 weight percent of at least one edible antimycotic agent; (d) about 0.5 to about 5 weight percent of lecithin or at least one modified lecithin; (e) about 0.3 to about 5 weight percent of at least one polysaccharide gum; (f) about 1 to about 10 weight percent of at least one flavorant; (g) about 1 to about 10 weight percent of at least one food starch or at least one modified food starch; (h) about 1 to about 10 weight percent of vegetable fat; (i) about 30 to about 70 weight percent of meat solids; and (j) about 3 to about 16 weight percent of animal fat. All of the weight percents are based on the total weight of the dried coating minus the moisture content thereof.

Abstract: A stopping for use in improving underground mine ventilation comprising an assembly of wall elements, said wall elements comprising:(a) a plurality of rigid blocks, and(b) a plurality of compliant sealing members. The rigid blocks and compliant sealing members are combined in courses to form a wall which extends over substantially the entire cross section of a tunnel being stopped, the sealing members being interposed between and/or around the rigid blocks in a uniform or nonuniform arrangement throughout the extent of the wall so as to (i) accommodate convergence loads imposed on the wall, and (ii) form, together with the rigid blocks, a barrier against the flow of gas through the tunnel.